Targeting the cause of Cystic Fibrosis
An NIHR-funded review looking at the effectiveness of a new drug at treating patients with Cystic Fibrosis has published its results in Health Technology Assessment.Cystic Fibrosis (CF) is a common disease that affects around 1 in every 2,500 babies born in the UK. It’s caused by a faulty gene and results in internal organs being...
Source: NIHR Evaluation, Trials and Studies News - Category: American Health Source Type: news
More News: American Health | Babies | Cystic Fibrosis | Genetics | Health | National Institute for Health Research (NIHR) | Study